Status:
UNKNOWN
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
Lead Sponsor:
The Center for Rheumatic Disease, Allergy, & Immunology
Collaborating Sponsors:
St. Luke's Hospital
Conditions:
Hepatitis C Patients
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to study the role of the Immune System in causing arthritis in patients with Hepatitis C.
Detailed Description
Patients will provide one blood sample after qualifying for the study, and signing consent. The patients will have a skin test TB, Candida, and Trichophyton placed and will read the results themselves...
Eligibility Criteria
Inclusion
- All adults 18 or older, 20 will have hep C positive with a viral load withen 6 mo. of enrollment.
- Either interferon or antiviral naive or those who failed interferon or antiviral therapy more than 6 mo. prior to enrollment.
- 10 normal healthy controls- Hep C neg and without osteoarthritis (OA).
Exclusion
- HIV patients
- Those with concomitant alcoholic liver disease
- Patients with Rheumatoid Arthritis (RA) or other autoimmune disorders.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01195987
Start Date
June 1 2010
End Date
August 1 2011
Last Update
September 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Rheumatic Disease, Allergy & Immunology
Kansas City, Missouri, United States, 64111